The Ceftizoxime Sodium, cataloged under National Stock Number 6505-01-185-3299, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Astellas Pharma Us, Inc.. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 3 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-185-3299 |
| Primary Part Number | NDC00469-7253-02 |
| Item Name | Ceftizoxime Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Astellas Pharma Us, Inc. |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 2.00 GRAMS CEFTIZOXIME EQUIVALENT G |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00469-7253-02 PRIMARY | Astellas Pharma Us, Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00469-7253-02 | 5/9 Secondary reference Lyphomed Inc Div of Fujisawa Usa Inc |
| CEFIZOX | 5/1 Secondary reference Astellas Pharma Us, Inc. |
| NDC57317-0253-02 | 5/9 Secondary reference Astellas Pharma Us, Inc. |
NSN 6505-01-185-3299 is a Ceftizoxime Sodium, manufactured by Astellas Pharma Us, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-185-3299 has 1 manufacturer part number on file: NDC00469-7253-02 (Astellas Pharma Us, Inc.).
3 possible matches (shared part number, not a government interchangeability claim): 6505-01-185-7855, 6505-01-274-9670, 6505-01-350-0359. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00469-7253-02: Administration: INTRAVENOUS; Primary Container Content Quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 6 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.